{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-060600","form_type":"8-K","ticker":"SNTI","cik":"0001854270","company_name":"Senti Biosciences, Inc.","filed_at":"2026-09-04T10:01:29+00:00","discovered_at":"2026-09-04T10:05:00.274416+00:00","generated_at":"2026-09-04T10:05:21.338875+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Senti Biosciences issues $2M convertible notes, secures $2.5M equity commitment from Celadon affiliate","bullets":["Issued $2.0M aggregate principal Senior Secured Convertible Notes to NSG BioInnovation Fund on Sept 3, 2026.","Notes mature Nov 23, 2026, repayable at 200% of principal; 12% default interest rate applies upon event of default.","Entered equity commitment letter with Celadon affiliate (CPIF II-9 Limited) to purchase $2.5M common stock at Nasdaq Minimum Price.","Shares to be purchased at closing of merger with Celadon affiliate; contingent value right up to $60M cash tied to SENTI-202 milestones.","Merger and CVR subject to stockholder approval; definitive proxy statement to be mailed after filing with SEC."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-060600","json":"https://secwatch.observer/filing/0001628280-26-060600.json","markdown":"https://secwatch.observer/filing/0001628280-26-060600.md","text":"https://secwatch.observer/filing/0001628280-26-060600.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1854270/000162828026060600/0001628280-26-060600-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1854270/000162828026060600/snti-20260903.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-04T10:05:21.338875+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}